Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Federal funding opportunity PAR-27-053 from National Institutes of Health (Department of Health and Human Services).

Apply on Grants.gov →Application closes June 16, 2028

Program funding history

Synopsis

Who can apply

• Special district governments
• City or township governments
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Native American tribal governments (Federally recognized)
• Small businesses
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Native American tribal organizations (other than Federally recognized tribal governments)
• Public and State controlled institutions of higher education
• State governments
• Private institutions of higher education
• County governments
• For profit organizations other than small businesses
• Independent school districts
• Public housing authorities/Indian housing authorities

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards. Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.

How to apply

Similar grants

• Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
  PAR-27-026 · National Institutes of Health · closes September 25, 2028
• NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
  PAR-24-089 · National Institutes of Health · closes November 13, 2026
• Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
  PAR-25-446 · National Institutes of Health · closes August 21, 2028
• Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
  RFA-DA-26-055 · National Institutes of Health · closes December 3, 2027
• Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
  RFA-DA-26-056 · National Institutes of Health · closes December 3, 2027
• Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
  PAR-25-100 · National Institutes of Health · closes May 7, 2027